Bhagiradha Chem. (BHAGCHEM)

FairStock Score: 22/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Debt/equity only 0.27, giving the balance sheet stability in a cyclical agrochemical business.
• Piotroski F-Score of 7/9 points to generally sound recent financial health.
• Sales growth of 10.94% shows demand for the products is still expanding.
• Profit growth of 28.69% indicates improving earnings momentum, albeit from a modest base.
• Latest quarter net profit of ₹5 Cr on ₹114 Cr sales keeps the business operationally positive.

Concerns

• Extreme valuation: P/E of 198.44, P/B of 5.36, and PEG of 10.01 imply no margin of safety.
• Weak capital efficiency: ROE of 3.81% and ROCE of 5.19% do not justify a premium multiple.
• Promoter holding of 19.60% is low, and dividend yield of 0.07% is negligible for minority shareholders.
• Thin net margin of roughly 4.4% leaves little cushion for any cost pressure or downturn.

AI Analysis

Let me apply the same standard I always use: is this a business I understand, does it earn high returns on capital, and can I buy it with a margin of safety? Bhagiradha Chem operates in pesticides and agrochemicals, which is understandable. But the numbers don't pass my test. The stock trades at ₹262.85, market cap ₹2,623 Cr, which is 198 times earnings and 5.36 times book value. That would be acceptable only if earnings power were exceptional. Instead, ROE is 3.81% and ROCE is 5.19%. A business that can't generate double-digit returns on equity doesn't deserve a premium to book. The latest quarter reported ₹114 Cr revenue and only ₹5 Cr profit, so the net margin is around 4.4%—thin and fragile. Sales growth of 10.94% is decent, and profit growth of 28.69% is encouraging, but PEG ratio of 10.01 tells me the current valuation is far ahead of realistic growth. Low leverage, at 0.27 debt-to-equity, and a Piotroski F-Score of 7/9 show the balance sheet is not the problem. The problem is price. With promoter holding only 19.60%, I don't have full confidence that my interests are aligned. Dividend yield of 0.07% means I'm not being paid to wait. The FairStock score of 9/100 is a red flag. I cannot justify ₹198 per rupee of earnings for a low-margin, low-return agrochemical business. In Graham's terms, the margin of safety is nonexistent. I'll pass and wait for a better price.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer